Borui Pharmaceutical (688166.SH) announced the results for the first three quarters, with net profit of 98.08 million yuan to mother, an increase of 94.92% over the previous year

According to Zhitong Finance App News, Borui Pharmaceutical (688166.SH) disclosed its report for the third quarter of 2026. In the first three quarters, the company achieved operating income of 994 million yuan, up 13.65% year on year; net profit attributable to shareholders of listed companies was 98.08 million yuan, up 94.92% year on year; after deducting non-net profit of 46.37 million yuan, up 0.44% year on year; basic earnings per share were 0.23 yuan.